- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 29, 2026 | 69.26M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 70.2M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 74.11M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $300M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Capex | Q1 2026 · Mar 31, 2026 | $24.3M |
| Capex | Q1 2026 · Mar 31, 2025 | $12.3M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $113.8M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $63.8M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $18.6M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $18.4M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.3B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.52B |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $1.33B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.21B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $687.5M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $680.1M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.68B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.68B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.71B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.91B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.99B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $3.19B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.30 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.50 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.30 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.50 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $317.2M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $260.7M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $89.7M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $59.6M |
| Net Income | Q1 2026 · Mar 31, 2026 | $91.1M |
| Net Income | Q1 2026 · Mar 31, 2025 | $35.4M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $122.1M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $88.8M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $529.1M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $409M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $232.7M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $159.9M |